Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;15(2):170-6.
doi: 10.1038/pcan.2011.43. Epub 2011 Sep 13.

Prevalence of BPH and lower urinary tract symptoms in West Africans

A P Chokkalingam  1 , E D Yeboah, A Demarzo, G Netto, K Yu, R B Biritwum, Y Tettey, A Adjei, S Jadallah, Y Li, L W Chu, D Chia, S Niwa, A Partin, I M Thompson, C Roehrborn, R N Hoover, A W Hsing
Affiliations

Prevalence of BPH and lower urinary tract symptoms in West Africans

A P Chokkalingam et al. Prostate Cancer Prostatic Dis. 2012 Jun.

Abstract

Background: BPH and lower urinary tract symptoms (LUTS) are very common among older men in Western countries. However, the prevalence of these two conditions in the developing countries is less clear.

Methods: We assessed the age-standardized prevalence of BPH and/or LUTS among West Africans in a probability sample of 950 men aged 50-74 in Accra, Ghana, with no evidence of biopsy-confirmed prostate cancer after screening with PSA and digital rectal examination (DRE). Information on LUTS was based on self-reports of the International Prostate Symptom Score (IPSS). BPH was estimated using DRE, PSA levels and imputed prostate volume.

Results: The prevalence of DRE-detected enlarged prostate was 62.3%, while that of PSA≥1.5 ng ml(-1) (an estimate of prostate volume ≥ 30 cm(3)) was 35.3%. The prevalence of moderate-to-severe LUTS (IPSS≥8) was 19.9%. The prevalence of IPSS≥8 and an enlarged prostate on DRE was 13.3%. Although there is no universally agreed-upon definition of BPH/LUTS, making comparisons across populations difficult, BPH and/or LUTS appear to be quite common among older Ghanaian men.

Conclusions: We found that after age standardization, the prevalence of DRE-detected enlarged prostate in Ghanaian men is higher than previously reported for American men, but the prevalence of LUTS was lower than previously reported for African Americans. Further studies are needed to confirm these findings and identify the risk factors for BPH in both Africans and African Americans.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of International Prostate Symptom Score (IPSS) by age, Ghanaian men aged 50–74, without prostate cancer.
See this image and copyright information in PMC

References

    1. Wei JT, Calhoun EA, Jacobsen SJ. Benign Prostatic hyperplasia. In: Litwin MS, Saigal CS (eds). Urologic Diseases in America DHHS, PHS, NIH, NIDDK—Government Printing Office: Washington, DC, 2007; pp 43–67.
    1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–479. - PubMed
    1. Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate Suppl 1996; 6: 67–73. - PubMed
    1. Girman CJ. Population-based studies of the epidemiology of benign prostatic hyperplasia. Br J Urol 1998; 82 (Suppl 1): 34–43. - PubMed
    1. Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549–1557. - PubMed

Publication types